Statistics for A phase II study of buparlisib in relapsed or refractory thymomas
Total visits
| views | |
|---|---|
| A phase II study of buparlisib in relapsed or refractory thymomas | 2 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
File Visits
| views | |
|---|---|
| java.util.UUID:09e94c22-8a1e-43ce-8946-992392d89a69 | 22 |
| java.util.UUID:217a1c99-1a18-44ea-a1fd-060692a1d5b6 | 18 |
| java.util.UUID:daa825f4-9f82-4adf-a95e-ae2cede406f7 | 11 |
| Zaid2022Phase-CCBY.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Franklin | 1 |
| Mooresville | 1 |